Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial...

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Lipid mediators like eicosanoids and specialized pro-resolving mediators (SPMs) play crucial roles in infection resolution.
• Macrophage polarization into M1 (pro-inflammatory) and M2 (pro-resolving) phenotypes dictates distinct cellular functions.

Purpose of the Study:

• To investigate the differential lipid mediator biosynthesis by human M1 and M2 macrophages upon exposure to pathogenic bacteria.
• To elucidate the role of calcium (Ca2+) and lipoxygenase (LOX) pathways in macrophage responses to bacterial stimuli.

Main Methods:

• Primary human macrophages (M1 and M2 phenotypes) were stimulated with pathogenic bacteria (E. coli, S. aureus).
• Lipid mediator profiles were analyzed using mass spectrometry.
• Subcellular localization of LOX enzymes and Ca2+ mobilization were assessed.

Main Results:

• Pathogenic E. coli and S. aureus induced predominantly pro-inflammatory leukotriene B4 and prostaglandin E2 in M1 macrophages.
• M2 macrophages produced SPMs, including resolvin D2 (RvD2) and RvD5, when stimulated by these bacteria.
• E. coli triggered Ca2+-dependent translocation of 5-LOX and 15-LOX-1 in M2 macrophages, while non-pathogenic strains did not.
• Resolvin D5 demonstrated higher potency than leukotriene B4 in enhancing macrophage phagocytosis.

Conclusions:

• M1 and M2 macrophages exhibit distinct lipid mediator signatures in response to pathogenic bacteria, producing either inflammatory or pro-resolving mediators.
• The findings highlight the differential roles of macrophage phenotypes in shaping the inflammatory or resolution phases of infection.
• Targeting specific lipid mediator pathways could offer novel therapeutic strategies for managing infections.